RARRES2 and metabolic dysfunction-associated steatotic liver disease: HCC-related upregulation of chemerin was influenced by disease etiology, and was observed in non-alcoholic fatty liver disease (NAFLD) and hepatitis B virus (HBV) infection, but not in hepatitis C virus (HCV)-positive patients.